VELCADE

Takeda Pharmaceuticals America, Inc.🇺🇸 United States

FDA Page

Effective Date: Oct 25, 2022
Approval ID: 1521d321-e724-4ffc-adad-34bf4f44fac7
Products: 1 registered
Version: 35

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use VELCADE safely and effectively. See full prescribing information for VELCADE. VELCADE(bortezomib) for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.